Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Induction chemotherapy in early-stage non-small-cell lung cancer.

× No keyword cloud information.

7 in total

1. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.

Authors: J A Roth; E N Atkinson; F Fossella; R Komaki; M Bernadette Ryan; J B Putnam; J S Lee; H Dhingra; L De Caro; M Chasen; W K Hong
Journal: Lung Cancer Date: 1998-07 Impact factor: 5.705

2. Revisions in the International System for Staging Lung Cancer.

Authors: C F Mountain
Journal: Chest Date: 1997-06 Impact factor: 9.410

3. Preoperative chemotherapy for lung cancer does not increase surgical morbidity.

Authors: M P Siegenthaler; K M Pisters; K W Merriman; J A Roth; S G Swisher; G L Walsh; A A Vaporciyan; W R Smythe; J B Putnam
Journal: Ann Thorac Surg Date: 2001-04 Impact factor: 4.330

4. Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial.

Authors: R Rosell; J Gómez-Codina; C Camps; J Javier Sánchez; J Maestre; J Padilla; A Cantó; A Abad; J Roig
Journal: Lung Cancer Date: 1999-10 Impact factor: 5.705

5. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

Authors: R O Dillman; J Herndon; S L Seagren; W L Eaton; M R Green
Journal: J Natl Cancer Inst Date: 1996-09-04 Impact factor: 13.506

6. Induction chemotherapy before surgery for early-stage lung cancer: A novel approach. Bimodality Lung Oncology Team.

Authors: K M Pisters; R J Ginsberg; D J Giroux; J B Putnam; M G Kris; D H Johnson; J R Roberts; J Mault; J J Crowley; P A Bunn
Journal: J Thorac Cardiovasc Surg Date: 2000-03 Impact factor: 5.209

7. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer.

Authors: W T Sause; C Scott; S Taylor; D Johnson; R Livingston; R Komaki; B Emami; W J Curran; R W Byhardt; A T Turrisi
Journal: J Natl Cancer Inst Date: 1995-02-01 Impact factor: 13.506

7 in total

1 in total

1. A randomised phase II trial of preoperative chemotherapy of cisplatin-docetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer results of a Japan Clinical Oncology Group trial (JCOG 0204).

Authors: H Kunitoh; H Kato; M Tsuboi; H Asamura; H Tada; K Nagai; T Mitsudomi; T Koike; K Nakagawa; Y Ichinose; M Okada; T Shibata; N Saijo
Journal: Br J Cancer Date: 2008-09-16 Impact factor: 7.640

1 in total